Core and Group Health

The projected specialty drug/biotech trend rate for 2015 is an exceptionally high 19.4 percent, according to the Segal Group.

Policymakers thought QHPs would sell themselves. Brokers and agents had to fight to get any opportunity to sell them.

As my previous career was that of a commodities floor trader where yelling over someone was a means to success, listening was not a practice I abided by when I entered the employee benefits business.

Premiums under the Patient Protection and Affordable Care Act are slated to increase by an average of 7.5 percent in 2015, according to preliminary analysis from PricewaterhouseCoopers Health Research Institute.

According to Benefits Sellings 2014 Employer Survey, 70 percent of employers said PPACA has made them rethink their employee benefit offerings, compared to 30 percent who said the health care reform law hadnt had any impact on their offerings.

If innovation is as Jay Abraham says, making obsolete that which you did before, then the small motley band of benefits professionals determined to revolutionize their business certainly qualifies.